Clinical Aspects of Tumor Necrosis Factor- Signaling in Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|17|2799-2808

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.17, 2014-05, pp. : 2799-2808

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumour Necrosis Factor-α Polymorphisms and Hepatocellular Carcinoma: a Meta-analysis

By Qin H   Liu B   Shi T   Liu Y   Sun Y   Ma Y  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 760-768

Field House Publishing

Access to resources Recommend Favorite

Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib

By  

Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. : 783-799

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric oxide and calcium signaling regulate myocardial tumor necrosis factor-α expression and cardiac function in sepsis

By Zhang Ting   Feng Qingping  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 2, 2010-02 ,pp. : 92-104

NRC Research Press

Access to resources Recommend Favorite

Impaired Intramembranous Bone Formation during Bone Repair in the Absence of Tumor Necrosis Factor-Alpha Signaling

By  

Cells Tissues Organs, Vol. 169, Iss. 3, 2001-06 ,pp. : 285-294

Karger

Access to resources Recommend Favorite

Role of Acyclic Retinoid in the Chemoprevention of Hepatocellular Carcinoma: Basic Aspects, Clinical Applications, and Future Prospects

By  

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-11 ,pp. : 1119-1128

Bentham Science Publishers

Access to resources Recommend Favorite